Brighton Jones’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,926
Closed -$169K – 1402
2026
Q2
$169K Buy
+16,926
New +$153K ﹤0.01% 1268

Other funds holding BCRX

Brighton Jones's BCRX Position: Q3 2026 in Review

Brighton Jones sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2026, closing a stake of 16,926 shares — an estimated $169K sold.

Brighton Jones first reported a position in BCRX in Q2 2026 and held it in 1 quarter. The position peaked at $169K in Q2 2026. 264 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.

  • Brighton Jones reported no remaining BioCryst Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 16,926 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $169K.
  • Brighton Jones first reported a position in BioCryst Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's BioCryst Pharmaceuticals position peaked at $169K in Q2 2026.
  • 264 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.